The second edition of ECCP 2010 will be held from 15 to 17 September in Oslo (Norway). This European oncology partnering event will bring together the top biotech companies, business development and licensing executives from the pharmaceutical industry, and innovative investors, researchers and doctors.
The ECCP is a business meeting created to encourage partnering between emerging and consolidated stakeholders in oncology, attract investment and establish alliances and collaborations in the fields of diagnostics, therapies, drug delivery, imaging and medical technology. This event, which specializes in one of the most significant fields of healthcare, offers attendees strong points like:
Focus on oncology.
An agenda that centers on partnering.
Pre-arranged, one-to-one meetings on an online platform.
Sessions, round tables, conferences, presentations and case studies.
Sponsors include companies and institutions like Amgen, Sanofi-Aventis, Merc&Co, Novartis, Pfizer, Bayer and the Enterprise Europe Network (EEN).
The previous edition, held in Toulouse, brought together 365 participants from 22 countries, representing 263 companies. More than 500 meetings were held.
The ECCP 2010 will take place in the Folketeateret, in the center of Oslo, and will begin with a reception at the Oslo Opera House on 15 September.
For more information on Biocat’s participation in ECCP 2010, send an email to email@example.com.